drugset / Trial / NCT06091553
Comparison of the Efficacy and Safety of Duloxetine Augmented With Gabapentin and Duloxetine Augmented With Amitriptyline vs Duloxetine Alone in Chemotherapy -Induced Neuropathy
RandomizedParallel-groupOpen-labelTreatment
Summary
This study aimed to elucidate the relationship between the Efficacy and Safety of Comparison of the Efficacy and Safety Duloxetine augmented with gabapentin and amitriptyline augmented with Duloxetine vs duloxetine alone in chemotherapy -Induced Neuropathy in cancer patients.
Timeline
- Start
- 2023-10-10
- Primary completion
- 2024-09-30
- Completion
- 2024-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Amitriptyline | Small molecule | 25 mg | — |
| Comparator | Duloxetine | Small molecule | 60 mg | — |
| Comparator | Gabapentin | Small molecule | 300 mg | — |